This image provided by Blue Origin shows the Blue Moon lander. Jeff Bezos' Blue Origin received a $3.4 billion contract Friday, May 19, 2023, to develop a lunar lander named Blue Moon. It will be used to transport astronauts to the lunar surface as early as 2029. (Blue Origin via AP)
By Marcia Dunn
Jeff Bezos' rocket company has won a NASA contract to land astronauts on the moon, two years after it lost out to SpaceX.
Blue Origin received a $3.4 billion contract Friday to lead a team to develop a lunar lander named Blue Moon. It will be used to transport astronauts to the lunar surface as early as 2029, following a pair of crew landings by Elon Musk’s SpaceX.
NASA will get astronauts to lunar orbit using its own rockets and capsules, but wants private companies to take over from there.
NASA Administrator Bill Nelson said the agency wants different landing options as it seeks a return to the moon more than a half-century after the end of the Apollo moonshots.
Blue Origin is kicking in billions of dollars, on top of the NASA contract, to help establish a permanent presence on the moon.
“We have a lot to do before we successfully land and return astronauts," said John Couluris, a Blue Origin vice president.
Two years ago, Blue Origin sued after NASA awarded SpaceX the contract for the first lunar landing. A federal judge upheld the space agency’s decision.
NASA’s Artemis program, which follows the 1960s and 1970s Apollo moonshots. kicked off with a successful test flight late last year. Launched atop NASA's new moon rocket, an empty Orion capsule went into lunar orbit before returning home.
The next Artemis flight will come late next year when one Canadian and three U.S. astronauts fly to the moon and back, but not land. Two Americans would descend to the lunar surface aboard a SpaceX Starship on the mission after that, no earlier than late 2025.
Like SpaceX, Blue Origin plans to practice landing on the moon without a crew, before putting astronauts on board.
While the shiny, stainless steel Starship has a science fiction look, Blue Moon resembles more of a traditional capsule perched atop a tall compartment with legs. The latter will stand 52 feet (16 meters) on the moon.
Both companies' landers are meant to be reusable.
Blue Origin will use its still-in-development New Glenn rocket to launch its lunar missions from Cape Canaveral. Starship, the world's largest rocket, made its debut last month from South Texas; the test flight ended in an explosive fireball a few minutes into flight.
Blue Origin's team includes five partners: Lockheed Martin, Boeing, Draper, Astrobotic Technology and Honeybee Robotics.
Only one other bid was submitted for the contract competition, according to NASA.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Catching you up on the stories you need to know this morning, mass shooting victims testify on Capitol Hill, the White House outlines its plan to vaccinate kids younger than five years old, and we break down how to protect yourself from monkeypox.
The pharmaceutical giant Moderna says its updated 'bivalent' booster shot provides a stronger immune response against the Omicron variant of COVID-19 specifically. This week, Moderna plans to submit preliminary data to U.S. health officials in the hopes that its new booster will be available later this summer. Dr. Sampson Davis, emergency medicine physician, joins Cheddar News to discuss.
NASA has announced that the first official full-color images will be beamed back to Earth from the James Webb Telescope on July 12. Gregory L. Robinson, the director of the James Webb Space Telescope Program in the NASA Science Mission Directorate, joined Cheddar News to discuss the anticipated image drop. “We expect to see the universe different," he said. "Webb will allow us to see much, much clearer and deeper into the universe."
On this episode of Cheddar Reveals, Professor Laurence Hurst, Director of The Milner Centre for Evolution, discusses the mystery of human evolution that's still baffling scientists: why are humans still evolving, and why has the process sped up? Neville Sanjana, faculty member at NY Genome and New York University, breaks down the latest innovations in CRISPR genetic engineering and its applications from 'designer babies' to curing genetic conditions and diseases; Cheddar gets a look at Curiosity Stream's 'The Butterfly Effect.'
Neville Sanjana, faculty member at NY Genome and New York University, joins Cheddar Reveals to break down the latest innovations in CRISPR genetic engineering and its applications from 'designer babies' to curing genetic conditions and diseases.
